Precision Optics Earnings Call Marks Profitable Inflection

Precision Optics Corporation, Inc. ((POCI)) has held its Q3 earnings call. Read on for the main highlights of the call.

Precision Optics Corporation, Inc. used its latest earnings call to spotlight a decisive turn in momentum, pairing record revenue with sharply better margins and its first quarter of positive adjusted EBITDA. Executives framed the quarter as a financial and operational inflection point, arguing that stronger yields, a healthier balance sheet and a growing pipeline outweigh near‑term risks linked to customer timing and ongoing manufacturing upgrades.

Record Quarterly Revenue Signals Strong Demand

Q3 revenue climbed to a record $8.7 million, more than doubling year over year from $4.2 million and rising about 17.6% from the prior quarter’s $7.4 million. Management credited robust demand across aerospace, single‑use medical devices and the Ross Optical unit, positioning the company for one of its strongest years on record.

Adjusted EBITDA Turns Positive for the First Time

Adjusted EBITDA reached a positive $300,000 in Q3, a sharp swing from a loss of $1.3 million a year ago and a $1.5 million loss in the prior quarter. Management highlighted this as a key sign that recent scaling efforts and cost controls are translating into operating leverage even as the company continues to invest in growth.

Gross Margin Expansion Drives Profitability Gains

Gross margin improved dramatically to about 24% in Q3, up from 10% in the year‑ago period and just 2.8% in Q2, lifting gross profit to $2.1 million from $418,000. Executives pointed to higher production volumes, better yields and a richer mix from higher‑margin businesses as drivers of the margin expansion.

Aerospace Program Delivers Record Revenue and Yields

Revenue from a top‑tier aerospace customer hit a record $3.6 million in Q3, representing 44% sequential growth and underscoring the strength of this flagship program. Production yields improved to roughly 97%, above the typical 85%–95% range, signaling meaningful efficiency gains in complex manufacturing.

Cystoscope Program Shows Growth and Yield Progress

Single‑use cystoscope revenue reached a record $2.2 million in Q3, growing around 10% sequentially as the product continues to scale. Production yields have moved above 90% and are expected to hit the 95% target in Q4, with ongoing process and cost improvements aimed at further boosting throughput and margins.

Ross Optical Boosts Growth and Margin Mix

Ross Optical contributed $1.3 million in Q3 revenue, up from $0.8 million a year earlier and $1.0 million in Q2, a 65% year‑over‑year increase. Management emphasized that this business carries higher margins and is expected to remain a meaningful contributor to overall profitability as it expands.

Balance Sheet Strengthened by Oversubscribed Offering

The company completed an oversubscribed $10 million public offering, lifting cash to $10.7 million at March 31 from about $900,000 at year‑end. With bank debt around $1.5 million, management said the reinforced balance sheet provides ample working capital to support scaling production and funding key investments.

Raised FY2026 Outlook Despite Ongoing Losses

While still reporting a Q3 net loss of $108,000 and guiding to a full‑year adjusted EBITDA loss, the company raised its FY2026 revenue outlook to $29 million–$31 million from $26 million–$28 million. Adjusted EBITDA guidance was narrowed to a loss of $2.5 million–$2.7 million, with Q4 expected to be roughly breakeven as operational momentum builds.

Development Pipeline and Unity Platform Gain Traction

Management highlighted an active development pipeline, expecting five to six programs to move into production in FY2027, with three transitions targeted in the next six months. The Unity platform is designed to shorten the path from R&D to production, with one active Unity program and four prospects that could each generate an estimated $1 million–$3 million in annual revenue.

Managing Aerospace Slowdown and Operating Constraints

A key aerospace customer has requested a production slowdown in the first half of FY2027 due to internal deployment bottlenecks, which Precision Optics estimates could trim quarterly revenue by 15%–20% during that window. Management also noted production remains spread across three Gardner, Mass. buildings, prompting evaluations of facility consolidation and modernization to support long‑term efficiency.

Tariff Pass‑Throughs and Revenue Concentration Risks

The company has negotiated tariff pass‑throughs that would have reduced reported Q3 revenue to $8.3 million but should benefit the bottom line as credits flow through. Management also acknowledged ongoing customer‑concentration risk, as large unnamed accounts like the lead aerospace program remain significant revenue drivers and limit disclosure detail.

Guidance Points to Strong Growth and Near Breakeven

Updated guidance calls for FY2026 revenue of $29 million–$31 million, implying 52%–62% growth over last year’s $19.1 million, with year‑to‑date revenue already at $22.8 million. The company expects Q4 to deliver roughly $6.2 million–$8.2 million in revenue, bringing adjusted EBITDA close to breakeven and setting a foundation for potential profitability as new programs enter production.

Precision Optics’ earnings call painted a picture of a company crossing important operational thresholds while still working through manufacturing refinements and customer‑timing risks. Record revenue, stronger margins and a fortified balance sheet suggest momentum is building, and investors will watch whether execution in coming quarters can convert this inflection into durable, profitable growth.